Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?When will tenofovir alafenide come off patent in canada?When will generic fiasap insulin be available?Guselkumab brand name?When oxcarbazepine patent expired?
Biosimilar Insulin Market – Quick‑Start Guide
*2023 values are based on a combination of market‑research reports (e.g., IQVIA, GlobalData) and publicly disclosed sales data.
Takeaway: The biosimilar insulin segment is growing steadily, with APAC showing the fastest expansion due to rising diabetes prevalence and a strong push for cost‑effective treatments.
Note: Several smaller biopharma companies are in the pipeline (e.g., Vetter, Zambon) targeting niche analogs (e.g., insulin degludec biosimilars) as patents on novel analogs expire.
Key takeaways:
Other Questions About Insulin :